Boston Partners lifted its position in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 1,561.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 148,042 shares of the medical technology company’s stock after purchasing an additional 139,132 shares during the period. Boston Partners owned about 0.32% of Teleflex worth $26,351,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Vontobel Holding Ltd. lifted its position in shares of Teleflex by 21.9% during the fourth quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock worth $248,000 after purchasing an additional 250 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after purchasing an additional 19,466 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Teleflex by 5.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock worth $19,263,000 after buying an additional 5,322 shares during the last quarter. Lecap Asset Management Ltd. bought a new stake in shares of Teleflex in the fourth quarter worth $729,000. Finally, Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Teleflex by 35.1% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock worth $1,053,000 after buying an additional 1,527 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on the stock. Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Truist Financial dropped their price target on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a research note on Monday, March 3rd. Finally, Wells Fargo & Company lowered their target price on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $182.63.
Teleflex Stock Down 0.7 %
Teleflex stock opened at $138.95 on Thursday. The company has a 50-day simple moving average of $164.60 and a 200-day simple moving average of $195.50. The firm has a market capitalization of $6.44 billion, a P/E ratio of 27.62, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a one year low of $128.55 and a one year high of $249.91.
Teleflex (NYSE:TFX – Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. As a group, equities analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.
Teleflex Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 0.98%. Teleflex’s dividend payout ratio is currently 95.77%.
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Stories
- Five stocks we like better than Teleflex
- How to Most Effectively Use the MarketBeat Earnings Screener
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Find and Profitably Trade Stocks at 52-Week Lows
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How is Compound Interest Calculated?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.